Molecular biomarkers in acute myeloid leukemia

J Prada-Arismendy, JC Arroyave, S Röthlisberger - Blood reviews, 2017 - Elsevier
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The
pathophysiology of this disease is just beginning to be understood at the cellular and …

Prediction of individual response to anticancer therapy: historical and future perspectives

FT Unger, I Witte, KA David - Cellular and molecular life sciences, 2015 - Springer
Since the introduction of chemotherapy for cancer treatment in the early 20th century
considerable efforts have been made to maximize drug efficiency and at the same time …

From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?

JP Bewersdorf, A Ardasheva, NA Podoltsev, A Singh… - Blood reviews, 2019 - Elsevier
Clonal hematopoiesis (CH) as defined by the presence of somatic mutations in genes
associated with myeloid neoplasms (MN) is common in healthy elderly individuals and does …

Mass spectrometry of peptides and proteins from human blood

P Zhu, P Bowden, D Zhang… - Mass spectrometry …, 2011 - Wiley Online Library
It is difficult to convey the accelerating rate and growing importance of mass spectrometry
applications to human blood proteins and peptides. Mass spectrometry can rapidly detect …

Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans

CG Julian, AW Subudhi, RC Hill… - Journal of Applied …, 2014 - journals.physiology.org
Our objective in this exploratory study was to identify novel biomarkers of importance for
acute mountain sickness (AMS) using discovery-based proteomic methods. Peripheral …

Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer

XH Li, C Li, ZQ ** molecular changes
K Kasaian, SJM Jones - Future oncology, 2011 - Taylor & Francis
Mutations in the genome of a normal cell can affect the function of its many genes and
pathways. These alterations could eventually transform the cell from a normal to a malignant …

Proteomics approaches for myeloid leukemia drug discovery

I Kapoor, P Pal, S Lochab, JK Kanaujiya… - Expert Opinion on …, 2012 - Taylor & Francis
Introduction: Global protein expression profiling between healthy vs diseased states helps
identifying differential expression and post-translational modifications of proteins, thereby …